Last Updated: June 22, 2026

SUCCINYLCHOLINE Drug Patent Profile

Name: SUCCINYLCHOLINE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

When do Succinylcholine patents expire, and what generic alternatives are available?

Succinylcholine is a drug marketed by Accord Hlthcare, Amneal, Amphastar Pharms Inc, Amring Pharms, Aspiro, Baxter Hlthcare Corp, Be Pharms, Breckenridge, Deva Holding As, Dr Reddys, Eugia Pharma, Fresenius Kabi Usa, Gland, Hikma, Intl Medication, Mankind Pharma, Meitheal, Micro Labs, Nexus, Nivagen Pharms Inc, Organon Usa Inc, Regcon Holdings, Sagent Pharms Inc, Somerset Theraps Llc, Zydus Pharms, and Steriscience. and is included in thirty NDAs. There is one patent protecting this drug.

The generic ingredient in SUCCINYLCHOLINE is succinylcholine chloride. There are six drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the succinylcholine chloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Succinylcholine

A generic version of SUCCINYLCHOLINE was approved as succinylcholine chloride by ZYDUS PHARMS on May 4^th, 2018.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for SUCCINYLCHOLINE?
What are the global sales for SUCCINYLCHOLINE?
What is Average Wholesale Price for SUCCINYLCHOLINE?

Summary for SUCCINYLCHOLINE

US Patents:	0
Applicants:	26
NDAs:	30
Drug Prices:	Drug price information for SUCCINYLCHOLINE
DailyMed Link:	SUCCINYLCHOLINE at DailyMed

Drug patent expirations by year for SUCCINYLCHOLINE

US Patents and Regulatory Information for SUCCINYLCHOLINE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Fresenius Kabi Usa	SUCCINYLCHOLINE CHLORIDE	succinylcholine chloride	SOLUTION;INTRAMUSCULAR, INTRAVENOUS	217884-001	Feb 11, 2025	AP	RX	No	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Hikma	SUCCINYLCHOLINE CHLORIDE	succinylcholine chloride	SOLUTION;INTRAMUSCULAR, INTRAVENOUS	215143-001	Aug 20, 2021		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial	Y			⤷ Start Trial
Accord Hlthcare	SUCCINYLCHOLINE CHLORIDE	succinylcholine chloride	INJECTABLE;INJECTION	213705-001	May 20, 2020		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Meitheal	SUCCINYLCHOLINE CHLORIDE	succinylcholine chloride	INJECTABLE;INJECTION	214514-001	Oct 19, 2021	AP	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Sagent Pharms Inc	SUCCINYLCHOLINE CHLORIDE	succinylcholine chloride	INJECTABLE;INJECTION	215022-001	Mar 29, 2021	AP	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

DrugChatter Q&A for SUCCINYLCHOLINE

Is succinylcholine a controlled substance?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.